Sana Biotech Fights Investor Fraud Claims Over Trial Data
Sana Biotechnology Inc. has asked a Seattle federal court to dismiss an investor suit over claims that it offered misleading statements regarding early clinical trials of a gene therapy, asserting that...To view the full article, register now.
Already a subscriber? Click here to view full article